Ongoing and planned clinical trials of anti-arrhythmic drugs: an update

Authors: Schron E.B.1; Friedman L.M.; Greene H.L.; Nwachuku C.

Source: Expert Opinion on Investigational Drugs, Volume 7, Number 3, March 1998 , pp. 427-435(9)

Publisher: Informa Healthcare

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Anti-arrhythmic drug therapy is frequently used for the control of ventricular arrhythmias in the setting of heart disease. These agents have been used in many randomised clinical trials in an attempt to demonstrate improved survival. However, most studies have been disappointing, showing little or no improvement in survival, and, in some cases, deterioration. This report reviews ongoing clinical trials designed to evaluate survival in specific patient populations.

Keywords: anti-arrhythmic drugs; implantable cardioverter defibrillator; sudden cardiac death; ventricular fibrillation; ventricular tachycardia

Document Type: Miscellaneous

Affiliations: 1: National Heart, Lung, & Blood Institute, Bethesda, MD 20892, USA NwachukuClinical Trials Scientific Research Group, Division of Epidemiology & Clinical Applications, National Heart, Lung, & Blood Institute, Bethesda, Maryland 20892, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$99.00 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A